Stevens, D R <br/><br/>
Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis.  [electronic resource] 

 -  Transplant infectious disease : an official journal of the Transplantation Society  Apr 2015 
 - 163-73 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1399-3062 
<br/><br/><label>Standard No.: </label>10.1111/tid.12349  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Academic Medical Centers<br/>Adult<br/>Allografts--virology<br/>Antiviral Agents--administration & dosage<br/>Cohort Studies<br/>Cytomegalovirus Infections--etiology<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Viral<br/>Female<br/>Ganciclovir--administration & dosage<br/>Graft Rejection--prevention & control<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Kidney Failure, Chronic--surgery<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Treatment Outcome<br/>Valganciclovir